Orion

Orion S.A. Navigates Q1 Headwinds with Modest Volume Gains but Margins Under Pressure

Wane_Investment_House

Invested

Community Contributor

Published

27 Jan 25

Updated

08 May 25

Views

n/a

Wane_Investment_House's Fair Value

n/a

-69.2%

10.7%

-69.2%

10.7%

You can edit this narrative until May 14 2:39 AM. Then, changes will post as Updates.

Author's Valuation

US$14.2863.2% undervalued

Wane_Investment_House's Fair Value

Narrative

Updates4

Shared on 08 May 25

WaneInvestmentHouse has increased revenue growth from 2.0% to 10.3%.

Shared on 27 Mar 25

Fair value Decreased 27%

WaneInvestmentHouse has decreased revenue growth from 14.5% to 2.0%, increased profit margin from 1.7% to 2.2% and decreased future PE multiple from 26.4x to 23.4x.

Shared on 14 Feb 25

Fair value Increased 3.58%

WaneInvestmentHouse made no meaningful changes to valuation assumptions.

Shared on 05 Feb 25

WaneInvestmentHouse made no meaningful changes to valuation assumptions.

Wane_Investment_House'sFair Value

US$14.28

63.2% undervalued

Future estimation in

Growth p.a.

Decrease

Increase

Current revenue growth rate

-0.57%

Chemicals revenue growth rate

0.60%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

11.68%

Calculation

US$44.84m

Earnings '27

23.36x

PE Ratio '27

US$1.05b

Market Cap '27

US$1.05b

Market Cap '27

56.76m

No. shares '27

US$18.45

Share Price '27

US$18.45 Share Price '27

Discounted to 2024 @ 8.92% p.a.

US$14.28

Fair Value '24